PGY2 oncology pharmacy residency; ASHP-accredited

ASHP-candidate status

Program description

The PGY2 oncology pharmacy residency is a full time, one year commitment, typically beginning on July 1 and ending on June 30. It is designed to transition PGY1 residency graduates from general practice to specialized practice focused on the care of patients in oncology. Residents will be accountable for achieving optimal drug therapy outcomes as an integral member of interdisciplinary health care teams. Furthermore, residents will develop and exercise their skills in oncology pharmacy operations, drug information, investigational pharmacy services, medication safety, and providing education to health care professionals, pharmacy students/residents, and patients. Graduates of the program will be prepared to provide clinical pharmacy services for solid tumor, malignant hematology, and stem cell transplant patient populations in both the acute and ambulatory care settings.

Learning experiences

Required experiences

• Adult Inpatient BMT (M Health Fairview, Minneapolis)
• AHCI Infusion Pharmacy
• Breast Oncology Outpatient
• GI Oncology Outpatient
• Intro to Inpatient and Outpatient Malignant Hematology
• Lung/Melanoma Outpatient
• Specialty Pharmacy Oral Chemotherapy Program

Elective experiences

• Advanced Inpatient and Outpatient Malignant Hematology
• Benign Heme Outpatient
• Hospice
• Infectious Disease
• Neuro-oncology Outpatient
• Oncology System Management
• Pediatric Malignancies (Children’s Hospital and Clinics, Minneapolis)
• Regional oncology pharmacy
• Palliative Care
• Other experiences may be developed based on interests of the resident

Longitudinal experiences

• Investigational agents
• Major Residency Project
• Medication use evaluation
• Mediation Safety
• Grand Rounds

Educational opportunities

• Teaching/precepting at the University of Minnesota, College of Pharmacy (Oncology course)
• UMOEN Journal Club
• Co-precept pharmacy students and PGY1 residents on oncology rotations
• Attendance at approved national, state and local meetings (e.g., HOPA Annual, ASHP Midyear Clinical, MSHP Annual)
• The above descriptions are highlights and not all inclusive. Please contact the Residency Program Director for more details. Additional rotations may be available based on the resident's interests and career goals.

Staffing

The resident staffs on the inpatient oncology unit every third weekend after introductory training is completed through the end of the residency year. Each resident will work two of six observed holidays.

Positions, salary and benefits

• One PGY-2 oncology pharmacy resident position
• Salary: $61,000
• Personal office space, personal computer, telephone and pager
• Health, dental and life insurance
• Paid time off
• Financial support for approved national, state and local pharmacy meetings
• Access to online resources through the University of Minnesota

Application process

Prerequisites

• Doctor of Pharmacy Degree from an ACPE-accredited school of pharmacy
• Completion of an ASHP Accredited PGY-1 Pharmacy Practice Residency
• Licensure as a Minnesota pharmacist
• Applicants must be currently authorized to work in the United States for any employer. No sponsorship is available for this position.

Application materials

• Enrollment in ASHP National Matching Service (match number 669760)
• Submit all application materials through the ASHP PhORCAS system; the deadline is January 2, 2025.
• Curriculum vitae
• Official college of pharmacy transcript(s)
• Letter of intent
• Letters of reference (3)